相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study
An-Wen Xiong et al.
FRONTIERS IN ONCOLOGY (2021)
An open-label, comparative, single dose, clinical Phase I study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults
Seuk Keun Choi et al.
VACCINE (2021)
Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)
Jeff Fairman et al.
VACCINE (2021)
Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions
Mark R. Alderson et al.
MICROORGANISMS (2021)
Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children
Priyanka D. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study
Mohammad Tahir Yousafzai et al.
Lancet Global Health (2021)
Surveillance of Salmonella enterica serovar Typhi in Colombia, 2012-2015
Paula Diaz-Guevara et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019
Farah N. Qamar et al.
CLINICAL INFECTIOUS DISEASES (2020)
Global Typhoid Fever Incidence: A Systematic Review and Meta-analysis
Christian S. Marchello et al.
CLINICAL INFECTIOUS DISEASES (2019)
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018
Samuel Kim et al.
CLINICAL INFECTIOUS DISEASES (2019)
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal
Mila Shakya et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines
Ravi P. N. Mishra et al.
BIOSCIENCE REPORTS (2018)
Vaccines for preventing typhoid fever (Review)
Rachael Milligan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
Celina Jin et al.
LANCET (2017)
A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions
Vittal Mogasale et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Prevalence and characterization of Salmonella among humans in Ghana
Linda Aurelia Andoh et al.
TROPICAL MEDICINE AND HEALTH (2017)
Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates
Michael Broeker
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
lmmunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials
Zulfiqar A. Bhutta et al.
LANCET INFECTIOUS DISEASES (2014)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Lisa A. Jackson et al.
VACCINE (2013)
Through the looking glass: understanding non-inferiority
Jennifer Schumi et al.
TRIALS (2011)
Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi
F. Micoli et al.
VACCINE (2011)
Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3
C. V. Srikanth et al.
SCIENCE (2010)
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults:: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory
Andres de Roux et al.
CLINICAL INFECTIOUS DISEASES (2008)
A clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccine
Vytautas Usonis et al.
VACCINE (2008)
Typhoid fever
CM Parry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)